ANTIVIRAL THERAPY, cilt.10, sa.2, ss.319-325, 2005 (SCI-Expanded)
Background: Our aim was to determine the short-term natural course of viraemia and the response to lamivudine treatment in HBeAg-negative chronic hepatitis B patients with a persistently low hepatitis B virus (HBV)-DNA level.